Institutional investors hold a majority ownership of AGN through the 82.95% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2016, these large investors purchased a net $22.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APPALOOSA LP Bought 3.0 Million shares of Allergan
EDGEWOOD MANAGEMENT LLC Bought 2.5 Million shares of Allergan
LEGAL & GENERAL INVESTMENT MANAG... Bought 1.7 Million shares of Allergan